Point-Counterpoint

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 1-6 of 6 total displayed.

Most recent content

Point/Counterpoint
The Case for a Gender-Neutral (Universal) Human Papillomavirus Vaccination Policy in the United States: Point

Anna R. Giuliano and Daniel Salmon
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 805-808. [Full text] [PDF]  

Point/Counterpoint
Human Papillomavirus Vaccination Should Be Offered to Young Males: Counterpoint

Cornelia L. Trimble
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 809. [Full text] [PDF]  

Past content

Point/Counterpoint
Tamoxifen or Raloxifene for Breast Cancer Chemoprevention: A Tale of Two Choices—Point

V. Craig Jordan
Cancer Epidemiol. Biomarkers Prev. 2007; 16: 2207-2209. [Full text] [PDF]  

Point/Counterpoint
Tamoxifen or Raloxifene in Postmenopausal Women for Prevention of Breast Cancer: A Tale of Two Choices—Counterpoint

Carol Fabian
Cancer Epidemiol. Biomarkers Prev. 2007; 16: 2210-2212. [Full text] [PDF]  

Point/Counterpoint
Point: Genetic Risk Feedback for Common Disease—Time to Test the Waters

Colleen M. McBride and Lawrence C. Brody
Cancer Epidemiol. Biomarkers Prev. 2007; 16: 1724-1726. [Full text] [PDF]  

Point/Counterpoint
Biospecimen "Ownership": Point

Roberta B. Ness on behalf of the American College of Epidemiology Policy Committee
Cancer Epidemiol. Biomarkers Prev. 2007; 16: 188-189. [Full text] [PDF]